Liquid-type formulation
Explore product form alongside its intended use.
BIOSTIMULATION · LIQUID PCL
Liquid
PCL.
A skin-quality
perspective.
Beginning with polycaprolactone. Aestyve Liquid PCL is positioned around skin quality—elasticity, texture and radiance. Explore its formulation concept and the research behind the material.
2.0 mL / VialPolycaprolactoneUltra-fine Particle Liquid
Explore the formulation ↗
MOVE TO EXPLORE
Brand-provided product image · refer to the supplied product labeling for pack configuration
LIQUID PCL / FOUR PERSPECTIVESBeyond volume.
Beyond volume.
A perspective on skin quality.
Understand Liquid PCL through four perspectives: formulation, material, skin structure and evidence.
PCL material
Begin with polycaprolactone as a material.
Skin-quality focus
A product direction centered on elasticity, texture and radiance.
Product-specific evidence
Distinguish material literature from supplied-product documentation.
AESTYVELiquid PCL
01 / FORMULATION & MATERIAL
A liquid feel.
A closer look at the material.
The brand describes a liquid-type formulation using ultra-fine particles. Particle presence, size and finished-product properties require product-specific documentation.
Ultra-fine particle liquid
The brand describes a formulation with a liquid-like feel. Confirm the particle-size distribution and concentration in current specifications.
Collagen-related research
Studies have examined collagen formation with PCL-based formulations. Research on other formulations is not a substitute for Aestyve product data.
A skin-quality focus
The product positioning centers on elasticity, texture and radiance. It does not guarantee a particular improvement or duration.
Product-specific assessment
Suitability is assessed by a qualified clinician using the authorized indication, IFU and individual skin condition.
How do ultra-fine particles differ from particle-free technology?
Very small particles are not the same as no particles. Visual clarity alone does not establish particle size or uniform tissue distribution. This page follows the brand-provided ultra-fine-particle description and distinguishes it from particle-free PCL research.
MATERIAL / STRUCTURE / EVIDENCEFrom particles
From particles
to a view of skin structure.
Explore the material and skin structure visually. Select a perspective to change the explanation.
FORMULATION CONCEPT
01 / FORMULATION CONCEPT
Understand particle form and formulation.
A liquid-type description and particle size are different information. Confirm actual size distribution, concentration and uniformity in product-specific specifications.
02 / SKIN STRUCTURE CONCEPT
Explore the structure of skin.
The dermis comprises cells and extracellular matrix, including collagen. This illustration explains structure; it does not depict a change after product administration.
03 / PRODUCT-SPECIFIC EVIDENCE
Read literature alongside product data.
PCL publications differ in formulation and study population. Material research does not replace product-specific clinical evidence; applicability must be assessed separately.
Concept visualization · not actual particle size, injection placement, tissue distribution or a before-and-after comparison.
A clear path to understanding the product.
Connect the product overview to your procurement review, step by step.
AESTYVELiquid PCL
02 / LIQUID vs THREAD
One material.
Different forms. Different assessments.
The material name PCL does not make products equivalent in mechanism or outcome.
THREAD FORMPARTICULATE FORM
| Item | PCL lifting thread | Aestyve Liquid PCL |
|---|---|---|
| Form | Solid thread; structure varies by product | Brand-described ultra-fine-particle liquid |
| Approach | Tissue support according to thread design and placement | Collagen- and skin-quality-oriented positioning |
| Tissue response | Varies with material, structure, location and assessment time | Requires formulation, concentration, distribution and product evidence |
| Use criteria | Authorization and IFU of the specific thread | Authorization and IFU of the supplied product |
A comparison of form and review criteria, not clinical superiority or equivalence.
AESTYVELiquid PCL
03 / LITERATURE
What the literature explores.
Evidence with context.
These four papers examine PCL materials, other formulations and threads. They do not report Aestyve Liquid PCL clinical outcomes.
Christen MO, Vercesi F.
2020
Clin Cosmet Investig Dermatol. 13:31–48.
A review of PCL biodegradation and its use as a collagen-stimulating material in aesthetics.
View publication ↗Kim JA, Van Abel D.
2015
J Cosmet Laser Ther. 17(2):99–101.
A two-patient pilot study examined tissue 13 months after injection of another PCL-based filler and observed collagen around particles.
View publication ↗Hong JY et al.
2021
Dermatol Ther. 34(2):e14770.
Evaluates safety, degradation and neocollagenesis of a particle-free PCL formulation in rats. Its technology differs from this product’s ultra-fine-particle description.
View publication ↗Cho SW et al.
2021
J Cosmet Dermatol. 20(9):2743–2749.
Compares PCL and other thread materials in mice. Tissue changes around threads cannot be transferred into efficacy figures for a liquid product.
View publication ↗AESTYVELiquid PCL
04 / PRODUCT DOSSIER
A basis for procurement.
Core information to verify against the current supplied-product documentation.
- Product
- Aestyve Liquid PCL
- Material
- Polycaprolactone / PCL
- Labeled volume
- 2.0 mL / Vial
- Formulation description
- Ultra-fine-particle liquid · brand-provided description
- Concentration / particle size
- Confirm in current product specifications
- Packaging / storage / expiry
- Refer to supplied-product labeling and IFU
- Intended use / availability
- Subject to local authorization and import requirements
AESTYVELiquid PCL
05 / BUYER FAQ
Questions buyers ask first.
How should efficacy and duration be assessed?
Review material literature separately from product-specific tests and clinical data. The supplied product’s authorized use and current IFU take priority; outcomes and duration can vary by individual and treatment conditions.
How do I ask about MOQ, price and samples?
Share your target country, company or clinic, quantity and timing. Availability, quotations and sample terms are confirmed individually.
Which documents should I request?
Start with current specifications, labeling and IFU, then ask about registration and batch-test documentation required for your market. Check that each document applies to the actual product and lot.
What is needed for overseas distribution?
Review target-market registration, import requirements and distribution qualifications. Publication of this page does not establish authorization to sell in a particular country.
AESTYVELiquid PCL
06 / START A CONVERSATION
Start your next review.
Share your country, quantity and timing to define the next steps.
info@aestyve.com ↗
Product · clinic · distribution inquiries
Product information for partners
Key product specifications
Polycaprolactone · 2.0 mL / Vial
Manufacturing & lot review
Manufacturing-document scope is reviewed against the supplied product’s label, lot and expiry. Manufacturing information is provided on a product-specific basis.
Product documentation
Request specifications, labeling / IFU, applicable finished-product CoA and registration documents. Document availability is confirmed for the product and destination market.
Market availability
Tell us your destination country and importing entity. Availability is confirmed after review of product-specific registration and import requirements.
Displayed specifications follow brand-provided information. Verify the current supply label and specifications when ordering.
Quality, reviewed through specific criteria.
We review raw-material and finished-product documentation according to the product’s characteristics and applicable specifications.
Composition & properties
Material identity, composition, concentration, pH and product-specific physical specifications
Finished-product testing
Applicable sterility or microbial, endotoxin and residual-substance test parameters
Lot traceability & packaging
Lot number, expiry, fill volume, package integrity and storage conditions
For PCL products, we review composition, concentration, particle-size distribution and formulation uniformity against product specifications.
We publish certifications and test values only when valid supporting documents have been verified for the relevant product, model, manufacturing site or lot. We check the issuer, issue date and scope, and distinguish raw-material results from finished-product results.
These are product-specific review criteria, not a statement that every product has completed every test or holds a certification.
AESTYVE / LIQUID PCLA perspective on skin.
A perspective on skin.
Liquid PCL.
Review product specifications and required documents, then start your next sourcing conversation.
Request Product Dossier ↗